The Johns Hopkins Transplant Infectious Diseases Prospective Cohort Study
Completed
Conditions studied: Transplantation
In brief
The Transplant Infectious Diseases Prospective Cohort Study facilitates the prospective identification and collection of data of infectious disease complications in order to determine the epidemiology, risk factors, and outcomes of patients who receive solid organ or stem cell or plastic surgery transplants at Johns Hopkins and other transplant centers. It is essential for the care and treatment of this population to employ a mechanism for investigators to centralize these datasets, using standardized definitions of infectious complications. This protocol outlines the procedures to be utilized in order to prospectively follow the diagnosis and treatment of infectious complications in transplant patients.
Key facts
- Study ID
- NCT01986504
- Run by
- Johns Hopkins University
- People needed
- 1058
- Starts
- 2011-06-01
- Expected to finish
- 2016-06-01
- Last updated by the study team
- 2016-07-19
Who can join
Age: 18 and older, up to 100. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Hematopoietic stem cell (bone marrow) and solid organ transplant patients -
Where it is running
- Johns Hopkins Hospital — Baltimore, Maryland, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.